Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Emissary Presents at Southwest Equity Capital Summit

  CEO Steven Mayo to Demonstrate Benefits of New Web Technology in Clinical
                               Research Studies

    AUSTIN, Texas, Oct. 1 /PRNewswire/ -- Emissary Inc. today announced that
it will participate in the 2002 Southwest Equity Capital Summit organized by
the Capital Network October 2-3 in Richardson, Texas.  Steven Mayo, founder
and CEO of Emissary, will present the company's plans to streamline drug and
medical device research studies with a new Web-based software initiative.
    Emissary is an international contract research organization with a team of
more than 200 research professionals.  Pharmaceutical, medical device and
biotechnology companies have relied on Emissary's rigorous, detail-focused
clinical trial services since 1995, and the company has distinguished itself
as a technology leader in the $8 billion contract clinical research industry.
Earlier this year, Emissary launched TeamTrials, a Web-based platform that
accelerates information exchange among researchers, study sponsors and
patients, delivering significant time and cost savings in comparison to
traditional paper-based clinical trials.

     WHO:   Steven Mayo, founder and CEO of Emissary

     WHAT:  Selected to present at the 2002 Southwest Equity Capital Summit

     WHEN:  October 2-3, 2002

     WHERE: Richardson, Texas

    About the Southwest Equity Capital Summit
    Organized by the Texas Capital Fund, the 2002 Southwest Equity Capital
Summit will feature 30 of the most promising companies in Texas and the
Southwest presenting their businesses to an audience of more than 400
attendees, including venture capitalists, private equity investors, corporate
investors, high net worth individuals and related finance professionals.
Presenting companies were chosen by a selection panel composed of executives
from premier venture and private equity firms in the Southwest.

    About Emissary Inc.
    Emissary Inc. is an international contract research organization (CRO)
providing clinical trial management services to the pharmaceutical, medical
device and biotechnology industries.  Emissary's experienced clinical research
teams ensure rapid development of life-saving and life-improving medical
products by making quality the priority in every clinical trial.  The company
is at the forefront of the CRO industry's effort to improve the clinical
trials process with TeamTrials(R), a comprehensive software initiative that
reduces the cost, time and complexity of clinical trials, benefiting patients,
investigators and researchers throughout the global clinical research
community.  Founded in 1995, Emissary maintains headquarters in Austin, TX,
with key affiliates located throughout North America and Europe.  For more
information, visit Emissary's Web site at http://www.Emissary.com .
    Emissary and TeamTrials are registered trademarks of Emissary Inc.

     Company Contact:                     Agency Contact:
     Chris Fallows                        Dabney Oliver
     Emissary Inc.                        Loomis Group
     Tel:  +1 (512) 918 1992              Tel:  +1 (512) 457 9400
     Fax: +1 (512) 918 8918               Fax: +1 (512) 457 1300
     cfallows@emissary.com                oliverd@loomisgroup.com



SOURCE Emissary Inc.




Back to Topback to top

Related links:
  • http://www.Emissary.com
    CONTACT:
    Chris Fallows of Emissary Inc.,
    +1-512-918-1992, or fax, +1-512-918-8918, or
    cfallows@emissary.com ; or Dabney Oliver of Loomis Group,
    +1-512-457-9400, or fax, +1-512-457-1300, or
    oliverd@loomisgroup.com , for Emissary Inc.